OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR/dCas9 Tools: Epigenetic Mechanism and Application in Gene Transcriptional Regulation
Ruijie Cai, Runyu Lv, Xin’e Shi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14865-14865
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

CRISPR-Based Gene Therapies: From Preclinical to Clinical Treatments
Marine Laurent, Marine Geoffroy, Giulia Pavani, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 800-800
Open Access | Times Cited: 13

Engineering strategies to safely drive CAR T-cells into the future
Matteo Rossi, Eytan Breman
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9

Enhancing precision in cancer treatment: the role of gene therapy and immune modulation in oncology
Emile M. Youssef, Brandon Fletcher, Dannelle Palmer
Frontiers in Medicine (2025) Vol. 11
Open Access

Epigenetic modulation by oncolytic viruses: Implications for cancer therapeutic efficacy
Muhammad Haris Sultan, Qi Zhang, Hao Jin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189270-189270
Closed Access

From bench to bedside: Developing CRISPR/Cas-based therapy for ocular diseases
Qing Zhao, L. J. Wei, Youxin Chen
Pharmacological Research (2025), pp. 107638-107638
Open Access

Utilizing CRISPR-based genetic modification for precise control of seed dormancy: progress, obstacles, and potential directions
Vinaykumar Rachappanavar
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access

CRISPR-dCas9-Mediated PTEN Activation via Tumor Cell Membrane-Coated Nanoplatform Enhances Sensitivity to Tyrosine Kinase Inhibitors in Nonsmall Cell Lung Cancer
Kaiyong Yang, Chunli Zhang, Zeyu Wang, et al.
ACS Applied Materials & Interfaces (2025) Vol. 17, Iss. 9, pp. 13605-13616
Closed Access

CRISPR/dCas9-KRAB mediated transcriptional suppression of NtbHLH47 enhances tolerance to iron stress and modulates iron content in tobacco.
Anshu Alok, Hanny Chauhan, Biswaranjan Rout, et al.
Plant Science (2025) Vol. 354, pp. 112449-112449
Closed Access

Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review
Paulina J. Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 705-705
Open Access | Times Cited: 4

Cas-based bacterial detection: recent advances and perspectives
Huatao Lan, Weitong Shu, Dan Jiang, et al.
The Analyst (2024) Vol. 149, Iss. 5, pp. 1398-1415
Closed Access | Times Cited: 3

Not Only Editing: A Cas-Cade of CRISPR/Cas-Based Tools for Functional Genomics in Plants and Animals
Aurélien Devillars, Gabriele Magon, Carlotta Pirrello, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3271-3271
Open Access | Times Cited: 3

Unlocking Plant Resilience: Advanced Epigenetic Strategies Against Heavy Metal and Metalloid Stress
Babar Iqbal, Naveed Ahmad, Guanlin Li, et al.
Plant Science (2024), pp. 112265-112265
Closed Access | Times Cited: 3

Epigenome editing strategies for plants: a mini review
Abirami T. Subramanian, Priyanka Roy, B. Aravind, et al.
The Nucleus (2024) Vol. 67, Iss. 1, pp. 75-87
Closed Access | Times Cited: 2

Boosting CAR-T cell therapy with CRISPR technology
Liyanran Yan, Shanzi Gao, Xinhui Wang, et al.
hLife (2024) Vol. 2, Iss. 8, pp. 380-396
Open Access | Times Cited: 2

Functional Genomics in Psoriasis
Stefano Rossi, Ellie Richards, Gisela Orozco, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7349-7349
Open Access | Times Cited: 2

Epigenome editing: a novel perspective towards ensuring global food security
Swapnil Baraskar, Anuradha Chetukuri, Venkata Chanda Sameer Kumar, et al.
The Nucleus (2024)
Closed Access | Times Cited: 2

Development and assessment of cutting-edge biotechnologies
Xiao Hu, Baichuan Xu, Mingliang Chen, et al.
Journal of Biosafety and Biosecurity (2024) Vol. 6, Iss. 1, pp. 51-63
Open Access | Times Cited: 1

Transforming the CRISPR/dCas9-based gene regulation technique into a forward screening tool in Plasmodium falciparum
Amuza Byaruhanga Lucky, Chengqi Wang, Xiaolian Li, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109602-109602
Open Access | Times Cited: 1

Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine
Sarkar Sardar Azeez, Rahin Shareef Hamad, Bahra Kakamin Hamad, et al.
Frontiers in Genome Editing (2024) Vol. 6
Open Access | Times Cited: 1

Induced proximity labeling and editing for epigenetic research
Chenwei Zhou, Sarah Wagner, Fu‐Sen Liang
Cell chemical biology (2024) Vol. 31, Iss. 6, pp. 1118-1131
Open Access

Unlocking biological mechanisms with integrative functional genomics approaches
Sehee Yun, Minsoo Noh, Jivin Yu, et al.
Molecules and Cells (2024) Vol. 47, Iss. 8, pp. 100092-100092
Open Access

Advances in CRISPR-Cas systems for epigenetics
Mahnoor Ilyas, Qasim Shah, Alvina Gul, et al.
Progress in molecular biology and translational science (2024), pp. 185-209
Closed Access

Recent progress in CRISPR-Cas-system for neurological disorders
Sarita Mishra, Shuvomoy Banerjee, Budhi Sagar Tiwari, et al.
Progress in molecular biology and translational science (2024), pp. 231-261
Closed Access

Page 1 - Next Page

Scroll to top